Mid Atlantic Bio Angels - aVenture Asset Manager Research
Location
New York City, NY, US
Founded
2012
Mid Atlantic Bio Angels (MABA) is a US-based venture capital firm specializing in early-stage investments in life science companies. MABA typically engages in various investment rounds, including Seed, Series A, and Series B, providing essential funding to innovative startups within the life sciences sector. The firm's focus is on fostering growth and development in companies that are poised to make significant advancements in medical and biotech fields.
Notable portfolio companies include Astrocyte Pharmaceuticals, Healionics, Immunomic Therapeutics, New View Surgical, Opsidio, PainQx, and Virion Therapeutics. MABA's founder, Yaniv Sneor, brings valuable insights into funding strategies and exit paths for young life science companies. The firm emphasizes a strategic approach to investment, leveraging its expertise to guide portfolio companies through critical growth phases. MABA also offers unique value-add services, such as mentorship and strategic advisory, to help startups navigate the complex landscape of the life sciences industry.
Mid Atlantic Bio Angels - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages